SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing heightened investor interest driven by a combination of strong institutional backing, including significant stake acquisitions by major funds, and growing momentum behind its U.S. solar manufacturing expansion. Community discussion is focused on the company's vertically integrated supply chain capabilities, the potential for a short squeeze due to elevated short interest, and the role of its upcoming Texas-based facilities in supporting AI data center infrastructure.

Enhanced Group, Inc. is an elite sports competition and performance products company committed to providing athletes and consumers with products that support health, performance, and recovery. The company offers a portfolio of products and experiences that combine athletic competition, scientific innovation, and consumer engagement. The company is headquartered in New York, NY.

Enhanced Group Inc. - Ordinary Shares - Class A

Enhanced Group Inc

Enhanced Group is trending following its recent NYSE listing and a string of high-profile partnerships, including a major streaming deal with Roku and a strategic agreement with creator platform Zoop. The community is focused on the upcoming inaugural Enhanced Games in Las Vegas, debating the company's ambitious model of blending sports entertainment with performance-enhancing health and telehealth services.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors react to a wave of positive clinical updates, including new patent protections and a strategic BCG supply agreement, while closely monitoring an FDA workshop focused on bladder cancer treatment protocols. The community is sharply divided between long-term supporters, who are encouraged by the potential for accelerated labeling and market dominance, and frustrated traders who continue to debate the impact of high short interest and institutional market mechanics on the share price.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending as investors monitor ongoing clinical developments, particularly its RNA-editing platform and the potential for a mid-2026 accelerated approval pathway for its lead AATD candidate. The community remains focused on the company's ability to drive value through key pipeline readouts and strategic positioning in the obesity and rare disease spaces.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. ($PURR) is trending as investors bet on its role as a proxy for the Hyperliquid ecosystem, with the stock seeing significant volatility tied to the performance of HYPE tokens and high-volume after-hours trading. Community sentiment is deeply divided between those who view it as a high-upside infrastructure play capitalizing on decentralized perpetual markets and those concerned about the lack of transparent guidance and the inherent risks of a digital treasury model.

XP, Inc. engages in the operation of technology-driven financial services platform. The firm provides customers with two principal types of offerings, financial advisory services for retail clients in Brazil, high-net-worth clients, international clients and corporate and institutional clients, and an open financial product platform providing access to over 800 investment products including equity and fixed income securities, mutual and hedge funds, structured products, life insurance, pension plans, real-estate investment funds (REITs) and others from XP, its partners and competitors. he company was founded by Guilherme Dias Fernandes Benchimol in 2001 and is headquartered in Vila Olimpia, Brazil.

XP Inc - Ordinary Shares - Class A

XP Inc. is trending as investors react to a new capital optimization plan, which includes a significant buyback program and planned dividend distributions, while the community remains divided over the firm's long-term growth prospects and the broader volatility of Brazilian financial stocks. Discussion is heavily focused on whether these capital return initiatives can stabilize the share price following a multi-year downtrend and ongoing skepticism regarding the company's reliance on specific high-volatility financial products.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics is experiencing significant market attention driven by positive clinical trial results for Tyvaso in treating idiopathic pulmonary fibrosis, alongside a new billion-dollar share repurchase program. Community discussion is heavily focused on the competitive dynamics between Tyvaso DPI and rival products like Liquidia's Yutrepia, while investors also monitor the impact of its strategic lung manufacturing initiatives and ongoing litigation.

LiveRamp Holdings, Inc. is a global technology company, which engages in the provision of a data collaboration platform in consumer privacy, data ethics, and foundational identity. The company was founded in 1969 and is headquartered in San Francisco, CA.

LiveRamp Holdings Inc

LiveRamp is surging following an acquisition agreement by Publicis Groupe, a deal that investors are actively debating for its implications on ad-tech consolidation and potential arb opportunities. Community sentiment reflects a mix of excitement over the exit premium and skepticism regarding the fairness of the sale price.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is seeing significant volatility following a strong earnings report and the announcement of a new advertising partnership with OpenAI, which the community sees as a major long-term catalyst. While some investors are frustrated by the stock's failure to maintain post-earnings momentum, many are actively accumulating shares on pullbacks, viewing the current price action as a shakeout before an eventual move higher.

FatPipe, Inc. engages in the development of software-defined wide area network (SD-WAN) solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. Its products include WARP, MPVPN, SD-WAN, Fatpipe Orchestrator, Next Gen Firewall, 5G and LTE, FatPipe Total Security 360, SASE, SIEM, EnterpriseView, and Cloud Connect. The company was founded by Ragula Bhaskar and Sanchaita Datta on October 14, 2010 and is headquartered in Salt Lake City, UT.

Fatpipe Inc.

FatPipe, Inc. Common Stock

FatPipe is gaining significant traction following positive news regarding expanded access to government and education procurement contracts, which has triggered heavy volume and speculative interest among retail traders. The community is actively discussing the potential for a massive short squeeze due to the stock's low float and limited share availability, with many focusing on whether this can replicate the parabolic runs seen in other recent momentum plays.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose, and Throat surgeons to utilize in providing improved treatment for their patients. The company was founded in 2003 by Don Eaton and is headquartered in Menlo Park, California, United States.

XENT
Intersect ENT Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest XENT News

XENTIntersect ENT Inc